Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

Even after Trump’s new deal, obesity drugs are still too expensive.

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Donald Trump's move to cut drug prices in America can potentially turn out to be a $35 billion additional cost to the federal ...

Under the arrangement, prices for GLP-1 drugs—used both for diabetes and obesity—will be slashed for Medicare and Medicaid beneficiaries. The prices of Ozempic and Wegovy will fall from $1,000 and $1, ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

As Ozempic use rises, society’s obsession with thinness is erasing body positivity and real, authentic bodies.

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Ozempic can cause stomach paralysis (gastroparesis), but it’s a rare side effect. The medication slows the movement of food from your stomach to your intestines, which helps you feel fuller and ...

Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President Donald Trump had suggested he might be able to bring the cost of popular weight-loss drugs ...

Some people may notice weight gain while using Ozempic or after stopping the drug. Reasons for weight gain while using Ozempic may include changes in appetite and reduced physical activity due to side ...